Lynnerup Jakob Tobias, Lillotte Tim, Feldmueller Maximilian, Anlahr Johanna, Bauer-Brandl Annette, Brandl Martin, Münster Uwe, Karl Maximilian
Drug Transport & Delivery Group, Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, 5230 Odense M, Denmark; Formulation Technology, INVITE GmbH, 51061 Cologne, Germany.
Formulation Technology, INVITE GmbH, 51061 Cologne, Germany.
J Pharm Sci. 2025 Aug;114(8):103884. doi: 10.1016/j.xphs.2025.103884. Epub 2025 Jun 21.
Our study aimed to both provide comprehensive mechanistic enlightenment of the dissolution, supersaturation, and precipitation behavior of different formulations using various sampling approaches, as well as evaluate the predictive capabilities by in vitro in vivo correlation (IVIVC). In vitro two-stage dissolution tests, that simulate the transfer from gastric to intestinal phases, using four different formulations at two dose strengths of the poorly water-soluble and weakly basic drug emodepside were performed. During the two-stage dissolution tests, five different sampling approaches were employed simultaneously (in situ 2 derivative UV spectroscopy, benchtop centrifugation, filtration, nanofiltration, and microdialysis). Comparison of the different fractions captured by alternative sampling approaches allowed for mechanistic understandings of the interrelated processes occurring during non-sink biomimetic dissolution of the various formulations (drug-rich submicron particles, bile salt micelle-association, supersaturation/precipitation). The selective insights into the various "dissolved" fractions are discussed in the light of analogous literature findings. Furthermore, the bio-predictive capabilities of the sampling approaches were evaluated by IVIVC. Microdialysis and nanofiltration reflected human oral bioavailability best, followed by conventional filtration and benchtop centrifugation, while in situ UV spectroscopy showed the poorest correlation. Analysis of molecularly dissolved drug thus appears to better predict formulation behavior in vivo.
我们的研究旨在通过各种采样方法,对不同制剂的溶解、过饱和和沉淀行为提供全面的机理启示,同时通过体外-体内相关性(IVIVC)评估预测能力。使用四种不同制剂,在两种剂量强度下,对水溶性差且呈弱碱性的药物依莫地吡进行了体外两阶段溶出试验,该试验模拟了从胃到肠阶段的转移过程。在两阶段溶出试验期间,同时采用了五种不同的采样方法(原位二阶导数紫外光谱法、台式离心法、过滤法、纳滤法和微透析法)。通过比较不同采样方法捕获的不同部分,能够从机理上理解各种制剂在非漏槽仿生溶出过程中发生的相关过程(富含药物的亚微米颗粒、胆盐胶束缔合、过饱和/沉淀)。结合类似的文献研究结果,对各种“溶解”部分的选择性见解进行了讨论。此外,通过IVIVC评估了采样方法的生物预测能力。微透析法和纳滤法对人体口服生物利用度的反映最佳,其次是传统过滤法和台式离心法,而原位紫外光谱法的相关性最差。因此,对分子溶解药物的分析似乎能更好地预测制剂在体内的行为。